Lorand Magdo
Overview
Explore the profile of Lorand Magdo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munteanu R, Moldovan C, Tigu A, Drula R, Feder R, Magdo L, et al.
Med Pharm Rep
. 2024 Nov;
97(4):488-506.
PMID: 39502764
Background And Aims: Non-small cell lung cancer (NSCLC) treatment is challenged by late detection and limited therapeutic options. Aberrant DNA methylation, a common epigenetic alteration in NSCLC, offers new therapeutic...
2.
Pruteanu L, Braicu C, Modos D, Jurj M, Raduly L, Zanoaga O, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563174
Triple negative breast cancer (TNBC) is currently associated with a lack of treatment options. Arsenic derivatives have shown antitumoral activity both in vitro and in vivo; however, their mode of...
3.
Cenariu D, Zimta A, Munteanu R, Onaciu A, Moldovan C, Jurj A, et al.
Pharmaceutics
. 2021 Jun;
13(5).
PMID: 34066331
Colon cancer is the third most common cancer type worldwide and is highly dependent on DNA mutations that progressively appear and accumulate in the normal colon epithelium. Mutations in the...
4.
Pop-Bica C, Pintea S, Magdo L, Cojocneanu R, Gulei D, Ferracin M, et al.
Front Oncol
. 2020 Nov;
10:516850.
PMID: 33194579
Non-small cell lung cancer (NSCLC) remains a problem worldwide due to its rapid progression and low rate of response to treatment. The heterogeneity of these tumors observed in histopathology exam...
5.
Pasca S, Ionescu C, Andras D, Eniu D, Muresan M, Magdo L, et al.
J Gastrointestin Liver Dis
. 2020 Sep;
29(3):361-367.
PMID: 32919420
Background And Aims: Although colon cancer has a decreasing incidence trend in Europe, because of its still high frequency and not fully understood pathogenesis, this malignancy still remains a subject...
6.
Cojocneanu R, Braicu C, Raduly L, Jurj A, Zanoaga O, Magdo L, et al.
Cancers (Basel)
. 2020 Apr;
12(4).
PMID: 32244548
An increasing number of studies suggest the implication of microRNAs (miRNAs) in colorectal (CRC) carcinogenesis and disease progression. Nevertheless, the basic mechanism is not yet clear. We determined plasma miRNA...
7.
Zimta A, Cenariu D, Irimie A, Magdo L, Nabavi S, Atanasov A, et al.
Cancers (Basel)
. 2019 Nov;
11(11).
PMID: 31717324
Nrf2 is a transcription factor that stimulates the expression of genes which have antioxidant response element-like sequences in their promoter. Nrf2 is a cellular protector, and this principle applies to...
8.
Braicu C, Buiga R, Cojocneanu R, Buse M, Raduly L, Pop L, et al.
J Exp Clin Cancer Res
. 2019 Oct;
38(1):433.
PMID: 31665050
Background: Bladder cancer (BC) is a common urothelial malignancy, characterized by a high recurrence rate. The biology of bladder cancer is complex and needs to be deciphered. The latest evidence...
9.
Boca S, Gulei D, Zimta A, Onaciu A, Magdo L, Tigu A, et al.
Cell Mol Life Sci
. 2019 Oct;
77(6):1059-1086.
PMID: 31637450
Concomitant with advances in research regarding the role of miRNAs in sustaining carcinogenesis, major concerns about their delivery options for anticancer therapies have been raised. The answer to this problem...
10.
Moisoiu V, Stefancu A, Gulei D, Boitor R, Magdo L, Raduly L, et al.
Int J Nanomedicine
. 2019 Aug;
14:6165-6178.
PMID: 31447558
Purpose: Surface-enhanced Raman scattering (SERS) spectroscopy on serum and other biofluids for cancer diagnosis represents an emerging field, which has shown promising preliminary results in several types of malignancies. The...